Graf Akcie ADVM (Adverum Biotechnologies Inc). Diskuze k akciím ADVM. Aktuální informace ADVM.

Základní informace o společnosti Adverum Biotechnologies Inc (Akcie ADVM)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 203.21M
Hodnota podniku (EV) N/A
Tržby 7.5M
EBITDA N/A
Zisk -138.17
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E -6.19
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 27.10
P/FCF N/A
Price/Book 0.47
Účetní hodnota na akcii 4.45
Hotovost na akcii 4.41
FCF vůči ceně -56.37 %
Počet zaměstnanců 167
Tržba na zaměstnance 44.910k
Profit margin N/A %
Operating margin -1,834.20 %
Gross margin N/A %
EBIT margin -1,827.41 %
EBITDA margin N/A %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 25.00 %
EPS - Očekávaný růst příští rok 19.35 %
Return on assets -27.94 %
Return on equity -32.64 %
ROIC -33.01 %
ROCE -27.11 %
Dluhy/Equity 0.11
Čistý dluh/EBITDA 16.30
Current ratio 18.82
Quick Ratio 18.82
Volatilita 6.38
Beta 0.88
RSI 42.13
Cílová cena analytiků 27
Známka akcie (dle analytiků) 1.22
Insider ownership 0.81 %
Institutional ownership 98.50 %
Počet akcií 98.126M
Procento shortovaných akcií 13.42 %
Short ratio 5.29 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie ADVM

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$0.25$1.612$1.849$1.455$2.319$0.572$0.48$0.03
Cost Of Goods Sold--------
Gross Profit$0.25$1.612$1.849$1.455$2.319$0.572$0.48$0.03
Research And Development Expenses$40.419$50.133$39.839$31.67$25.462$16.976$2.151$1.31
SG&A Expenses$28.376$24.56$20.857$24.355$22.107$7.998$1.783$0.536
Other Operating Income Or Expenses--------
Operating Expenses$68.795$79.693$60.696$116.739$50.142$24.974$3.934$1.846
Operating Income$-68.545$-78.081$-58.847$-115.284$-47.823$-24.402$-3.454$-1.816
Total Non-Operating Income/Expense$4.059$4.204$2.7$0.762$0.37$-1.002$-1.822$0.005
Pre-Tax Income$-64.486$-73.877$-56.147$-114.522$-47.453$-25.404$-5.276$-1.811
Income Taxes-$-1.25-$-0.775----
Income After Taxes$-64.486$-72.627$-56.147$-113.747$-47.453$-25.404$-5.276$-1.811
Other Income--------
Income From Continuous Operations$-64.486$-72.627$-56.147$-113.747$-47.453$-25.404$-5.276$-1.811
Income From Discontinued Operations--------
Net Income$-64.486$-72.627$-56.147$-113.747$-47.453$-28.634$-5.276$-1.811
EBITDA$-66.077$-71.307$-56.158$-52.967$-46.231$-24.24$-3.408$-1.812
EBIT$-68.545$-78.081$-58.847$-115.284$-47.823$-24.402$-3.454$-1.816
Basic Shares Outstanding64614436251244
Shares Outstanding64614436251244
Basic EPS$-1.01$-1.18$-1.29$-3.14$-1.86$-2.46$-1.44$-0.50
EPS - Earnings Per Share$-1.01$-1.18$-1.29$-3.14$-1.86$-2.46$-1.44$-0.50
# 2020 2019 2018 2017 2016 2015
Current Ratio9.061719.475118.150722.764239.700629.2959
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100100100100
Operating Margin-27418-4843.735-3182.639-7923.299-2062.225-4266.083
EBIT Margin-27418-4843.735-3182.639-7923.299-2062.225-4266.083
EBITDA Margin-26430.8-4423.511-3037.209-3640.343-1993.575-4237.762
Pre-Tax Profit Margin-25794.4-4582.94-3036.615-7870.928-2046.27-4441.258
Net Profit Margin-25794.4-4505.397-3036.615-7817.663-2046.27-5005.944
Asset Turnover0.00110.00760.00920.00620.00880.0035
Inventory Turnover Ratio------
Receiveable Turnover---1.64225.1648-
Days Sales In Receivables---222.261270.6706-
ROE - Return On Equity-36.8582-36.1028-30.5109-52.7584-18.7864-16.9946
Return On Tangible Equity-36.8582-36.1028-31.3621-54.0109-18.7864-16.9946
ROA - Return On Assets-28.9529-34.0181-27.8086-48.489-17.9529-15.6906
ROI - Return On Investment-36.8582-36.1028-30.51-52.7584-18.7864-16.9946
Book Value Per Share2.59853.19493.75455.15739.76846.5695
Operating Cash Flow Per Share0.11220.1610.01820.3284-0.90210.1074
Free Cash Flow Per Share-0.17490.17120.06140.3794-0.93870.0512